Whole foot treatment | Targeted Treatment | |||||||
---|---|---|---|---|---|---|---|---|
Lesion stageb | No. viable | No. non-viable | Viable (%) | No. viable | No. non-viable | Viable (%) | p value | |
Baseline (day 0) | All lesions | 139 | 0 | 100 | 146 | 0 | 100 | n.a. |
stage 2 | 126 | 0 | 100 | 132 | 0 | 100 | n.a. | |
stage 3 | 13 | 0 | 100 | 14 | 0 | 100 | n.a. | |
First follow-up (day 2) | All lesions | 32 | 105 | 23.4 | 10 | 132 | 7.0 | <0.001 |
stage 2 | 31 | 92 | 25.2 | 8 | 116 | 6.5 | <0.001 | |
stage 3 | 1 | 13 | 7.1 | 2 | 16 | 11.1 | 0.600 | |
Second follow-up (day 5) | All lesions | 15 | 105 | 12.5 | 5 | 122 | 3.9 | 0.018 |
stage 2 | 14 | 95 | 12.8 | 5 | 109 | 4.4 | 0.030 | |
stage 3 | 1 | 10 | 9.1 | 0 | 13 | 0 | 0.458 | |
Third follow-up (day 7) | All lesions | 6 | 128 | 4.5 | 3 | 137 | 2.1 | 0.326 |
stage 2 | 5 | 115 | 4.2 | 3 | 120 | 2.4 | 0.496 | |
stage 3 | 1 | 13 | 7.1 | 0 | 17 | 0.0 | 0.452 |